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Interleukin (IL)–1 family members are key players in inﬂammatory processes but have been the subject of
few studies of acquired immunodeﬁciency syndrome (AIDS). To better evaluate the impact of the IL-1 family
on AIDS development, we genotyped the IL1a, IL1b, IL1Ra, and IL1R1 genes in 245 slow progressor (SP) and
82 rapid progressor (RP) human immunodeﬁciency virus type 1–seropositive patients as well as in 446 control
subjects, all of whom were of white ethnicity. One hundred sixteen frequent polymorphisms were identiﬁed,
of which 23 were newly characterized by our study. Many putative associations were found between single-
nucleotide polymorphism (SNP) or haplotype alleles and the extreme proﬁles of progression. Most of them
corresponded to weak associations ( ); however, the SNP IL1Ra_2134 exhibited a consistent as- .01 ! P ! .05
sociation, found at the level of the SNP, haplotypes, and haploblocks, when the SP and control populations
were compared ( ). The IL-1–dependent inﬂammatory response is, thus, likely to play a role in AIDS P p .0002
progression via the regulation of IL-1Ra expression. This association will need to be conﬁrmed in other AIDS
cohorts, and experiments will also have to be performed to unravel the biological mechanisms at work. The
data presented here will be useful for future genomic studies of the IL-1 family members in other infectious
and chronic inﬂammatory diseases.
Interleukin (IL)–1 is a key player in inﬂammatory re-
sponses and can induce various effects that range from
fever induction to the increase of the lymphocyte re-
sponse [1–3]. The term “IL-1” usually designates a
group of 3 molecules; 2 of them, IL-1a and IL-1b,a r e
biologically active, and the third member, IL-1Ra, is a
receptor antagonist whose function is to moderate the
effects of IL-1a and IL-1b [4, 5].
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The role played by cytokines in the development of
HIV-1 infection has been extensively investigated [6,
7], but relatively few studies have dealt with the mem-
bers of the IL-1 family. This is surprising, in light of
the importance of IL-1 in inﬂammation and in the
response to infectious diseases, but it is understandable,
given that AIDS is mainly known as a disease of adap-
tive immunity [8]. The balance between IL-1a/b and
IL-1Ra has been reported to modulate HIV-1 expres-
sion in monocytes [9, 10]—IL-1Ra has been shown to
reduce HIV-1 levels in monocytes, whereas IL-1a/b
have been shown to induce HIV-1 expression [11, 12].
Similarly, antiretroviral therapy (ART) caused a reduc-
tion of IL-1a/b levels and an increase of IL-1Ra levels
in lipopolysaccharide-stimulated HIV-1–infected mono-
cytes [13]. Other studies have pointed out interactions
such as an activation of IL-1b production in neuro-
blastoma cells in vitro by the gp120 protein of HIV-1IL-1 Genes and AIDS Progression • JID 2006:194 (1 December) • 1493
envelope [14] and an inhibition of IL-1a expression in vitro
by the viral protein Tat [15]. Furthermore, it has been showed
that caspase-mediated IL-1b processing can play a major role
in CD4
+ T cell survival and HIV-1 proliferation [16].
Only few genetic association studies regarding the impact of
IL-1 family members on AIDS have been conducted to date—
the ﬁrst study showed that a tandem-repeat polymorphism in
the IL1Ra gene was associated with reduced HIV-1 levels [17],
another study linked single-nucleotide polymorphisms (SNPs)
in IL1a with the control of HIV viremia in patients receiving
highly active ART (HAART) [18], and a third study investi-
gating a few polymorphisms in IL1a,I L 1 b, IL1Ra, and IL1R1
found no association with AIDS progression [19].
Our group previously completed the exhaustive genotyping
of Th1/Th2 cytokines and their receptor genes [20, 21] and
looked for associations with AIDS progression in the Genetics
of Resistance to Immunodeﬁciency Virus (GRIV) cohort. As a
continuation of this previous work and to clarifytheroleplayed
by IL-1 family members in AIDS, we present here the extensive
genotyping of the IL1a,I L 1 b, IL1Ra, and IL1R1 genes and their
associations with AIDS progression in the GRIV cohort, which
is composed of 2 subpopulations of HIV-1–seropositive white
individuals with extreme progression phenotypes and living in
France: slow-progressor (SP) patients and rapid-progressor(RP)
patients. We also genotyped healthy control subjects of similar
ethnic origin. The GRIV patients correspond to the extreme
1% subset of a cohort of 30,000 seroconverter patients [22]
and is, as far as we know, the largest cohort of its kind in the
world. Its quality has already been conﬁrmed for several gene
polymorphisms, such as CCR5 [23–25] and HLA [26, 27].
The IL1a,I L 1 b, IL1Ra, and IL1R1 genes are located in the
2q12–2q14 region of chromosome 2. IL1a and IL1b are spaced
by 40 kb, IL1Ra is 280 kb telomeric from IL1b, and IL1R1 is
11 Mb centromeric from IL1a (ﬁgure 1A). IL1a,I L 1 b, and
IL1Ra likely derive from the same ancestral gene [2, 3]. In the
present study, SNPs and other genetic variations of the IL-1
family members were identiﬁed through sequencing. The data
gathered were used to compute the genetic structure of the IL-
1 family locus (linkage disequilibrium and haploblocks) and to
evaluateassociationswithAIDSsusceptibilityanddevelopment.
SUBJECTS, MATERIALS, AND METHODS
The GRIV cohort. The GRIV cohort was established in 1995
in France to generate a large collection of DNA for genetic
studies of candidate polymorphisms associated with rapid and
slow progression to AIDS. Only white individuals of European
descent living in France were recruited. These criteria limit the
inﬂuence of the virogenetic and environmental factors (all sub-
jects are infected by B strains and live in a similarenvironment)
and puts emphasis on the genetic makeup of each individual
to determine the various patterns of progression. SP patients
were deﬁned as individuals who had been seropositive but
asymptomatic for 8 or more years with a CD4
+ cell count 1500
cells/mm
3 in the absence of ART. RP patients were deﬁned as
those who had a decrease in their CD4
+ cell count to !300
cells/mm
3 in !3 years after the last seronegative test. DNA was
obtained from fresh peripheral-blood mononuclear cells or from
Epstein-Barr virus–transformed cell lines. The control subjects
were seronegative white individuals of European descent living
in France. In the present study, we genotyped up to 245 SP
patients, 82 RP patients, and 446 control subjects.
Genotyping. The primers and conditions used for poly-
merase chain reaction ampliﬁcation of the different fragments
are shown in table 2. Sequencing reactions were performed by
the Dye Terminator method, using an ABI PRISM 3700 DNA
analyzer (Applied Biosystems). Alignment, SNP discovery,
and genotyping were done with the software Genalys (version
3.3.24a), developed by the Centre National de Ge ´notypage[34].
For practical reasons, an initial screening was performed on
150 SP patients, 50 RP patients, and 150 control subjects for
polymorphism discovery. The screening was then extended to
include more subjects when a positive ( ) or borderline P  .05
( ) association was detected. P ! .1
Hardy-Weinberg equilibrium (HWE). HWE analysis was
performed for each SNP in each group according to the stan-
dardmethod: theexperimentalgenotypicdistributionwascom-
pared with the theoretical distribution estimated on the basis
of the SNP allelic frequencies, and a P value could thus be
derived. It is important to assess the deviations from HWE
( ), because it suggests an effect of the SNP if a deviation P ! .05
is observed in a case group, and it suggests a mistake in the
genotyping otherwise [35, 36].
Haplotypes. Haplotype estimates were obtained using the
expectation-maximization (EM) algorithm [37] and the phase
2 algorithm [38, 39] either for all polymorphismsorforselected
ones.
Linkage disequilibrium and haploblocks. Linkage dis-
equilibrium was computed for each pair of polymorphisms by
the standard r
2 method [40] or the standard D
 method [41].
A haploblock is a genetic region for which no evidence of a
historical recombination event can be found—in other words,
the SNPs located in that region exhibit a signiﬁcant level of
linkage disequilibrium (D
 close to 1). The haploblocks in the
genes were computed using the method developed by Gabriel
et al. [42], which is used by the software Haploview (version
3.2; available at: http://www.broad.mit.edu/mpg/haploview/)
[43]. The haplotype tagging (HT) polymorphisms are the poly-
morphisms that are sufﬁcient to describe the genetic variation
inside a haploblock. These HT polymorphisms were also com-
puted using Haploview and served as a basis for the estimation
of subhaplotypes in the computed haploblocks.
Statistical analyses. Statistical analyses were performedonly1494
Figure 1. Genetic mapping. A, Positions of the IL1a,I L 1 b, IL1Ra, and IL1R1 genes on the 2q12–2q14 locus. B, Map of the IL1a,I L 1 b, IL1Ra, and
IL1R1 genes. Coding and untranslated regions are respectively indicated by black and white rectangles. The regions that have been sequenced are
indicated by a horizontal line, with start and end positions enumerated in reference to the ﬁrst nucleotide of the initiation codon as +1. The initiation
codon is indicated by a black triangle, and a name is provided for each isoform of interleukin (IL)–1Ra (soluble [s] and intracellular [Ic] isoforms). The
polymorphism nos. are their positions relative to the initiation codon as +1 (correspondence with the dbSNP database is given in table 1). The newly
characterized polymorphisms are indicated by an asterisk. The genomic sequence used for alignment of the 4 genes is NT_022135.14.1
4
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Table 1. IL1a,I L 1 b, IL1Ra, and IL1R1 polymorphisms.
Gene Position A1 A2
Allelic
frequency (A1), %
Nominal P values and ORs from statistical tests
b
References to previous
studies of the
variant and new IDs
SP vs. CTR RP vs. CTR SP vs. RP vs. CTR
CTR RP SP Localization
a AF OR D/R OR G AF OR D/R OR G AF
IL1a 472 A T 30.97 28.70 24.48 Intron 1 .083 1.384 .064 (D) 1.550 .169 .716 .208 rs3783525
IL1Ra 2134 T G 81.75 74.62 71.17 Intron 2 .002 1.814 .0002 (R) 2.389 .001 .114 .088 (R) 0.587 .008 rs2232354
3105 C A 77.27 82.81 80.34 Intron 2 .517 .064 (D) 0.155 .380 .595 ss52090882 (new)
5103 T C 76.00 67.97 71.22 Exon 4 (Ser130Ser
c) .094 1.279 .071 (R) 1.399 .063 0.670 .080 (R) 0.606 .059 rs315952 [28]
5385 C G 76.21 68.75 71.60 3
-UTR .104 .079 0.687 .081 rs315951
5409 C T 96.32 92.19 95.43 3
-UTR .505 .054 0.451 .085 (R) 0.485 .095 rs4252041
5784 G A 96.38 98.08 99.29 3
-UTR .022 0.192 .021 (R) 0.186 .016 .530 .055 ss52090883 (new)
IL1R1 16233 T A 81.49 83.02 82.31 Promoter .833 .772 .077 .930 ss52090886 (new)
16069 G A 63.31 65.09 67.69 Promoter .266 .049 (R) 0.629 .053 .815 .528 rs956730
15858 C T 63.31 65.09 67.69 Promoter .266 .049 (R) 0.629 .053 .815 .528 rs2234650 [29]
186 C T 80.79 84.26 81.69 Intron 1 .833 .471 .023 .727 rs2287048
131 G A 63.64 66.67 70.50 Intron 1 .080 0.732 .010 (R) 0.531 .010 .641 .057 .211 rs2287047
9171 G T 68.21 72.55 71.58 Intron 6 .421 .457 .022 .576 rs2160227
10974 G T 68.40 72.64 72.60 Intron 7 .276 .460 .024 .488 ss52090890 (new)
13941 G T 68.09 72.12 72.54 Intron 7 .242 .464 .029 .462 ss52090891 (new)
19349 C G 75.17 75.47 74.82 3
-UTR .923 .039 (D) 3.378 .029 1.000 .990 rs3917324
NOTE. Indicated for each polymorphism are the allelic frequencies in the different populations (control [CTR], rapid progression [RP], and slow progression [SP]), the localization and the amino acid change (when
applicable), the P values from Fisher’s exact tests (and odd ratios [OR] when applicable), and the relevant information known to date. A1 represents the nucleotide that is identical to the reference sequence, which is
NT_022135.14 for the 4 genes. The amino acid positions are taken from the references sequences NP_000566.3 (interleukin [IL]–1a), NP_000567.1 (IL-1b), NP_000868.1 (IL-1R1), NP_776214.1 (soluble [s]IL-1Ra),
NP_776213.1 (IL-1RaIcI), NP_000568.1 (IL-1RaIcII), and NP_776215.1 (IL-1RaIcIII). The polymorphism nos. correspond to their position relative to the initiation codon as +1, and the corresponding dbSNP numbers are
also given in the far right column. The calculation modes for the Fisher’s exact tests are indicated (AF , allelic frequency; D/R, dominant/recessive; G, genotypic distribution). Positive (P.05) and borderline ( ) P !.1
correlations are shown in boldface. For the dominant/recessive mode, the mode corresponding to the allele A1 is indicated in parenthesis. The P values for the dominant/recessive and genotypic distribution calculation
modes are shown only if !.1. UTR, untranslated region.
a Exon and introns are indicated for sIL1Ra, unless otherwise speciﬁed.
b Bonferroni corrections were not performed on P values.
c The amino acid change corresponds to all 4 isoforms, but the position corresponds only to the soluble isoform (sIL1Ra). The positions for the other isoforms are 133 (IcI), 112 (IcII), and 96 (IcIII).1496 • JID 2006:194 (1 December) • Do et al.
Table 2. Primers used to amplify the exons of
IL1a,I L 1 b, IL1Ra, and IL1R1bypolymerasechain
reaction (PCR).
The table is available in its entirety in the online
edition of the Journal of Infectious Diseases.
Table 3. Frequency of polymorphisms identiﬁed in genes of the interleukin (IL)–1
family.
Parameter
Gene
Total IL1a IL1b IL1Ra IL1R1
Frequent polymorphisms 27 10 35 44 116
Newly identiﬁed 4 2 2 14 22
Located in exons 6 1 8 12 27
Synonymous 0 1 2 1 4
Nonsynonymous 1 0 0 1 2
UTR 5 0 6 10 21
bp sequenced 8510 4670 6380 14,600 34,160
Frequency, polymorphism/bp sequenced 1/315 1/467 1/182 1/332 1/294
NOTE. Data are no. of polymorphisms, unless otherwise speciﬁed. UTR, untranslated region.
on the polymorphisms (and haplotypes) with a minor allele
frequency 11% in our entire population, termed “frequent
polymorphisms.” The differences in the allelic distributions
(SNPs or haplotypes) between the 3 populationswereexamined
as follows: for each allele (with a frequency 11% in the entire
population), the expected numbers of individuals in each pop-
ulation with and without that allele werecomparedbyaFisher’s
exact test. Four modes of calculation were used for the genetic
analysis: allelic frequency, dominant mode, recessive mode,and
genotypic distribution. For SNPs, there are only 2 alleles, and
the P value for the dominant mode on one allele is identical
to the P value for the recessive mode on the other allele. As a
consequence, table 1, which concerns individual polymor-
phisms, combines the dominant and recessive modes. Bonfer-
roni corrections were not performed because, in such candi-
date-gene association studies, conﬁrmation in other cohorts is
more relevant [22].
RESULTS
SNP discovery. We systematically screened the IL1a, IL1b,
IL1Ra, and IL1R1 genes for polymorphisms by sequencing the
exons with their ﬂanking regions as wellasthepromoterregion.
We identiﬁed 116 frequent polymorphisms (minor allele fre-
quency 11% in our entire population) in these genes, most of
them being SNPs (ﬁgure 1B). Of these 116 polymorphisms, 27
were in the IL1a gene, 10 were in the IL1b gene, 35 were in
the IL1Ra gene, and 44 were in the IL1R1 gene (ﬁgure 1B); 22
of these 116 polymorphisms were newly characterized in our
study. On average, we found 1 polymorphism with a frequency
11% in every 294 bp (table 3), which is consistent with the
ﬁndings of previous studies [44, 45]. The allelic frequencies
obtained in our study were compared with the data from the
National Center for Biotechnology Information’s dbSNP da-
tabase (available at: http://www.ncbi.nlm.nih.gov/SNP/) when
the allelic frequencies were available for the European popu-
lation. Our results are consistent with dbSNP allelicfrequencies
except for the SNPs IL1a_3769, IL1b_289, and IL1R1_–16069,
whose allelic frequencies exhibit differences 110%, compared
with those in dbSNP.
IL-1 family gene structure. The 4 genes IL1a,I L 1 b, IL1Ra,
and IL1R1 are neighbors in the same chromosomal region (ﬁg-
ure 1A). IL1a,I L 1 b, and IL1Ra are very close to each other
(!300 kb) and, thus, were investigated for linkage disequilib-
rium between their polymorphisms by use of the softwareHap-
loview [43]. As shown in ﬁgure 2A, IL1a,I L 1 b, and IL1Ra
present strong intragenic linkage disequilibrium (195%), but
there is no intergenic linkagedisequilibriumbetweenthemeven
though these genes lie relatively close to each other on the
chromosome. Figure 2B–2E presents the haploblocks for each
gene, which correspond to groups of polymorphisms that have
never undergone any recombination; we found 1 haploblock
for the gene IL1a, 2f o rIL1b, 3f o rIL1Ra, and 3 for IL1R1.
As shown in table 4, all the SNPs ﬁtted with Hardy-Weinberg
equilibrium in the SP, RP, and control populations.
Associations with AIDS progression: SNPs. The GRIV case-
control study is based on the comparison of the allelic distri-
butions of the polymorphisms between the patient populations
(SP and RP patients) and the control subjects. Table 1 presents
the allelic frequencies in each population, their locations, and
P values (the abridged version of the table that appears in the
print edition of the Journal includes only polymorphisms with
positive [ ] or borderline [ ] associations; the com- P ! .05 P ! .1
plete results for all polymorphisms with a frequency 11% are
given in the version of the table included in the electronic
edition of the Journal).IL-1 Genes and AIDS Progression • JID 2006:194 (1 December) • 1497
Table 4. Genotypic frequencies and Hardy-
Weinberg equilibrium (HWE) P values for all
identiﬁed polymorphisms in the IL1a, IL1b,
IL1Ra, and IL1R1 genes.
The table is available in its entirety in the online
edition of the Journal of Infectious Diseases.
Figure 2. Haploblock analysis. The ﬁgure and legend are available in
their entirety in the online edition of the Journal of Infectious Diseases.
In the IL1a gene, no polymorphism exhibited any positive
association, but the SNP IL1a_–472 exhibited a borderline as-
sociation (table 1). In the IL1b gene, no polymorphism exhib-
ited any positive or borderline association. In the IL1Ra gene,
2 SNPs exhibited positive associations (table 1). The lowest P
value was obtained for the intronic SNP IL1Ra_2134 (P p
in the dominant/recessive mode) for the comparison be- .0002
tween the SP population and the control population (table 1).
In the IL1R1 gene, 8 polymorphisms exhibited positive asso-
ciations (table 1). Two were located in the promoter region, 5
were located in introns, and one was located in the 3
 untrans-
lated region. The promoter SNPs did not correspond to known
transcription factor binding sites. The lowest P value was ob-
tained for IL1R1_–131, located in intron 1 ( in the P p .010
dominant/recessive and genotypic distribution modes) for
the comparison between the SP population and the control
population.
Of note, of the 10 polymorphisms exhibiting positive asso-
ciations, only IL1Ra_2134 remained signiﬁcant for the simul-
taneous comparison of the 3 populations by the x
2 test (table
1). This conﬁrms that comparing the populations is more 22
sensitive [21].
Associations with AIDS progression: haplotypes. For each
gene, the haplotypes were estimated using the phase 2 and EM
algorithms for the polymorphisms with a minor allelic fre-
quency 15% and for the promoter polymorphisms as well. The
haplotypes based on the nonsynonymous SNPs (protein vari-
ants) were not estimated, because each gene contained nomore
than 1 nonsynonymous SNP. Table 5 presents the haplotype
data; the estimated haplotypes exhibiting a positive ( ) P  .05
or borderline ( ) association for comparisons between the P ! .1
populations are shown in the abridged versionofthetablegiven
in the print edition of the Journal, and the detailedcomposition
of all haplotypes is shown in the complete version of the table
given in the electronic edition of the Journal.
For the IL1a gene, we identiﬁed positive associations for the
haplotype IL1a_over5%_3 ( in the dominant mode) P p .013
for the comparison between the SP population and the control
population. For the IL1b gene, we identiﬁed positive associa-
tions for IL1b_over5%_0 ( in the recessive mode) and P p .026
IL1b_over5%_1 ( in the dominant mode) for the P p .048
comparison between the SP population and the control pop-
ulation. For the IL1Ra gene, we identiﬁed positive associa-
tions for 3 haplotypes. The lowest P value was found for
IL1Ra_over5%_0 ( in the dominant mode) for the P p .0002
comparison between the SP population and the control pop-
ulation. The association for this haplotype can be entirely ex-
plained by the SNP IL1Ra_2134. No positive association was
identiﬁed for the haplotypes of IL1R1, and no positive asso-
ciation was identiﬁed for the haplotypes based on the poly-
morphisms located in the promoter regions of the genes (data
not shown).
We have presented here the results based on SNPs with a
minor allelic frequency 15%, to clarify the presentation. We
have also performed the haplotype analysis with all the poly-
morphisms found in each gene, and the resultsthatweobtained
were identical (data not shown).
Haploblocks. Haploblocks are presented in ﬁgure 2. HT
SNPs were computed for the haploblocks IL1a_Block1,
IL1b_Block2, IL1Ra_Block1, IL1R1_Block1, and IL1R1_Block3.
The other haploblocks were only composed of 2 polymor-
phisms in linkage disequilibrium and, thus, did not presentany
interest for this calculation. We computed the haplotypes
(which we have termed “HT haplotypes”) derived from these
HT SNPs and tested them for associations with AIDS pro-
gression (table 6). No positive association was found for the
HT haplotypes of IL1a or IL1R1, but some of them presented
borderline associations (table 6). For IL1b, the HT haplotypes
H0 and H2 of the main haploblock presented positive asso-
ciations for the comparison between the SP populations and
the control population table 6: these HT haplotypes were sub-
haplotypes of the larger haplotypes that were derived from all
the SNPs and that exhibited a positive association (table 5).
The second haploblock of IL1b is minor, because it contains
only the 2 polymorphisms IL1b_–1061 and IL1b_–581, which
were in linkage disequilibrium. For IL1Ra, the HT haplotype
IL1Ra_H0 presented a positive association ( in the P p .0001
allelic frequency mode and in the dominant mode) P p .00002
for the comparison between the SP population and the control
population (table 6). A positive association was also obtained
when the 3 populations were compared for this haplotype
( ). IL1Ra_H0 was the only subhaplotype that pre- P p .0005
sented the allele G for the SNP IL1Ra_2134. Furthermore,
IL1Ra_H0 is a subhaplotype of IL1Ra_over5%_0, which also
exhibited a positive association (table 5) and is linked to the
SNP IL1Ra_2134. Thus, the association with AIDS progression
for the HT haplotype IL1Ra_H0 is likely due to the effect of
the SNP IL1Ra_2134. The HT haplotype IL1Ra_H1 also pre-
sented a positive association ( ) in the recessive mode P p .0251498
Table 5. Estimated haplotypes of IL1a,I L 1 b, IL1Ra, and IL1R1 with an allelic
frequency 11%.
Polymorphism Haplotype
IL1a_over5%
1 3
3120 A A
3087 T T
2992 G G
2230 T C
1926 C C
1613 C C
578 C C
472 A T
460 A G
1143 C A
1171 G G
1264 C T
1376 C T
3747 – A
3769 A G
3996 A A
4009 T T
4125 G G
4697 T C
5910 G G
5953 C A
8463 C A
9112 A A
9265 T T
9632 –––– TTCA
Global allelic frequency, % 26.17 11.56
Allelic frequency, %
CTR 31.95 8.65
RP 31.71 7.32
SP 24.44 15.79
Nominal P value
SP vs. CTR
AF .067 .017
D .066 .013
RP vs. CTR, AF 1.000 .822
SP vs. RP vs. CTR, AF .128 .016
IL1b_over5%
0 1 2 5
1061 C T C T
5 8 1 TCTC
2 8 9 TCTC
3340 A G G G
(continued)1499
Table 5. (Continued.)
Polymorphism Haplotype
3417 C C T T
5014 G G A A
5050 –– –– TT TT
5254 CCCC
5505 A G G G
Global allelic frequency, % 45.33 18.34 16.23 2.12
Allelic frequency, %
CTR 41.86 21.32 16.67 1.16
RP 40.48 21.43 19.05 1.19
SP 50.95 14.29 14.76 3.81
Nominal P value
SP vs. CTR
AF .051 .054 .612 .071
D .048 .068
R .026
RP vs. CTR
AF .899 1.000 .620 1.000
R .067
SP vs. RP vs. CTR, AF .094 .118 .652 .119
IL1Ra_over5%
0 4 9
10237 G G C
10124 C C T
9988 A A C
9777 G G A
9696 G G A
9640 A A G
9621 G G C
9574 T T C
9452 C C G
9432 A A G
7667 G G C
7492 A A C
5905 G A G
2006 T T C
2061 C C T
2072 G G A
2093 G G C
2134 G T T
2137 A A C
2198 G G A
2257 G G T
2282 C T C
3105 C C C
3264 A A G
(continued)Table 5. (Continued.)
Polymorphism Haplotype
3269 C C G
3356 G G A
3378 T T C
3592 A A T
3699 A T A
5103 T C T
5385 C G C
6211 G G A
6574 T T C
Global allelic frequency, % 22.80 12.01 1.13
Allelic frequency, %
CTR 18.50 11.02 0.00
RP 23.61 19.44 2.78
SP 32.52 11.17 0.97
Nominal P value
SP vs. CTR
AF .0007 1.000 .200
D .0002
RP vs. CTR
AF .400 .073 .048
D .049 .048
SP vs. RP vs. CTR, AF .0024 .132 .178
IL1R1_over5%
11
16323 A
16233 T
16069 A
15858 T
15832 C
15517 A
15218 G
14892 C
14804 A
186 C
131 A
6982 T
7465 C
7727 G
7895 T
7982 G
8249 A
8868 G
9171 G
10390 T
10649 A
10974 G
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Table 5. (Continued.)
Polymorphism Haplotype
13941 G
14225 A
14590 A
17197 G
17377 ––
18576 A
18691 A
19349 G
20098 A
20357 C
20419 A
21679 G
Global allelic frequency, % 2.36
Allelic frequency, %
CTR 4.46
RP 2.50
SP 1.43
Nominal P value
SP vs. CTR, AF .090
RP vs. CTR, AF .738
SP vs. RP vs. CTR, AF .167
NOTE. Indicated for each haplotype are the global frequency, the frequency in each
population (control [CTR], rapid progression [RP], and slow progression [SP]), the P value
from Fisher’s exact tests for the comparisons SP vs. CTR, RP vs. CTR, SP vs. RP , and SP
vs. RP vs. CTR, and the calculation mode (allelic frequency [AF], dominant [D], andrecessive
[R]). Positive ( ) and borderline ( ) comparisons are shown in boldface. The P P.05 P !.1
values for the D and R calculation modes are shown only if !0.1. The haplotypes presented
are based on polymorphisms with a minor allelic frequency 15%. Tagging polymorphisms
for the different haplotypes are shaded.
Table 6. Detailed information for the haplo-
types derived from the haplotype tagging (HT)
single-nucleotide polymorphism of haploblocks
of IL1a,I L 1 b, IL1Ra, and IL1R1.
The table is available in its entirety in the online
edition of the Journal of Infectious Diseases.
for the comparison between the SP population and the control
population.
DISCUSSION
We undertook the exhaustive genotyping of the IL1a,I L 1 b,
IL1Ra, and IL1R1 genes to look for genetic factors involved in
AIDS progression. The interest in such a study is to provide
clues to the molecular mechanisms of disease developmentand
help for the rational design of new diagnostic or therapeutic
targets.
Of 116 frequent polymorphisms detected in the IL-1 family
genes, 22 were newly characterized in our study. We identiﬁed
10 polymorphisms exhibiting positive associations ( ) P  .05
and 6 other polymorphisms exhibiting borderline associations
( ) with AIDS progression (table 1). We identiﬁed 6 hap- P ! .1
lotypes exhibiting positive associations (table 5). These positive
associations were found by comparing the SP population with
the control population or the RP population with the control
population, which was the basis of the present case-control
study. It is noteworthy that comparison of the RP, SP, and
control populations simultaneously appears to be less sensitive,
given that only 1 association of 10 remained positive for the
polymorphisms and 2 of 6 remained positiveforthehaplotypes.
Almost all polymorphisms involved in an association were
located in introns, and their biological effect is, thus, difﬁcult
to interpret. Only 3 SNPs exhibiting a positive association were
located in a promoter region, all in the promoter region of
IL1R1 (table 1). Two of these SNPs were in full linkage dis-
equilibrium, and they belonged to the same haploblock. The1502 • JID 2006:194 (1 December) • Do et al.
haplotypes derived from these promoter SNPs did not exhibit
any positive or borderline associations (data not shown). The
biological effect of the promoter SNPs on IL-1R1 expression
is at present unknown, and we did not ﬁnd any similarity with
previously described transcription factor binding sites. Thus, it
will be of interest to perform reporter gene experiments or
competitive gel shift assays, to determine whether the alleles of
these SNPs can have a differential effect on gene expression.
Most of the associations for the individual polymorphisms
were rather weak, with P values between .01 and .05, except
for the intronic SNP IL1Ra_2134 ( , in the dominant/ P p .0002
recessive mode) for the comparison between the SP population
and the control population. Similarly, most of the associations
found for haplotypes and HT haplotypes were weak (.01 !
), except for the ones linked with the SNP IL1Ra_2134 P ! .05
(table 5). We also evaluated whether sex, age, or route of in-
fection could inﬂuence these results; there was no such inﬂu-
ence (data not shown).
The allele IL1Ra_2134G was carried by 32.12%, 44.62%, and
53.06% of the control, RP, and SP populations, respectively.
Because the P value comparing the RP and control populations
was also low for this allele ( ), there was a possibility P p .08
that this SNP could be associated with susceptibility to HIV-1
infection rather than with disease progression;we thusanalyzed
180 seropositive subjects from the SEROCO cohort [46] and
found that the distribution of the alleles for this SNP was iden-
tical to that of the control population (data not shown). The
effect of IL1Ra_2134 is, thus, mainly associated with slow dis-
ease progression. This SNP is located next to a well-known
variable-number tandem repeat of IL1Ra (located in the same
intron) that has been associated with many diseases [4, 47],
including AIDS [17]. This repeat is composed most often by
two or by four 86-bp units, but it could not be genotyped in
the present study because of technical reasons. There have been
contradictory reports of the IL1Ra*2 allele (2-U repeat) being
associated with higher [48, 49] or lower [50] levels of IL-1Ra.
The association found for the IL1Ra_2134 SNP emphasizes the
importance of this intronic region, and experiments will have
to be performed to determine whether the effect is mediated
solely through this SNP or through linkage disequilibriumwith
this variable-number tandem repeat.
Besides the study of this repeat conducted by Witkin et al.
[17], there have been 2 other studies of the associationbetween
the IL-1 gene family and AIDS. Wang et al. [19] reported no
association between AIDS and the SNPs IL1b_–1061 and
IL1b_3417, which is consistent with our results. Price et al. also
identiﬁed associations between the control of HIV-1 replication
and the SNPs IL1a_–1613 and IL1a_4125 (which are in linkage
disequilibrium) in patients receiving HAART [18]. Of note, the
allele IL1a_1613T has been associated with increased IL-1a
expression [51, 52] but none of these SNPs exhibited any as-
sociations in our study. The SNPs IL1b_1061, IL1b_581,
IL1b_3417, IL1a_1613, IL1a_4125, and IL1Ra_2006 have
been associated with other diseases, such as rheumatoid ar-
thritis [30], osteoarthritis [53–55], periodontal disease [52],
asthma [56, 57], allergic rhinitis [58], and lupus [59]. None of
these SNPs presented a positive association in our study.
In the present study, we thoroughly investigated the genes
of the IL-1 family (IL1a,I L 1 b, IL1Ra, and IL1R1), providing
an important set of information. We identiﬁed new polymor-
phisms in these genes and also found putative associations be-
tween some polymorphisms, haplotypes, and haploblocks of
these genes with AIDS progression. Of all the associations, one
appears to be strongest, pointing to an intronic SNP in IL1Ra;
this SNP deﬁnitely deserves more extensive analyses, either by
genetic association investigations in other AIDS cohorts or by
further biological experimentation to assess its impact on IL-
1Ra expression. Another interesting methodological observa-
tion, which conﬁrms the observation made in our previous
work [21], is that use of the case-control comparisons is 22
more sensitive for the detection of associations. On the other
hand, it appears more robust to compare simultaneously the
3 populations.
Cytokine receptors are an assembly of 2 or more subunits,
which are all required for efﬁcient ligand binding and signal
transduction. The a subunit IL-1R1 studied here is involved
in both ligand binding and intracellular signaling, but the b
subunit IL-1RacP (accessory protein) is required for efﬁcient
signal transmission [5]. There is another receptor in this family,
IL-1R2, which preferentially binds to IL-1b. Its intracellular
domain is very short, and it apparently fails to initiate any bio-
logical response [60]. It is believed to act as a naturalmoderator
for IL-1. Our work will, thus, need to be completed by the
analysis of these last 2 members of the IL-1 family.
The important amount of data provided and the putative
associations discovered in this work will be useful for future
genetic association studies of the role IL-1 family membersplay
in HIV-1 infection. Given the importance of IL-1 in the in-
ﬂammatory process, this information should also prove to be
useful for the study of other infectious and chronic inﬂam-
matory diseases.
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